---
title: "Sulfasalazine - Juvenile Rheumatoid Arthritis"
sidebar: mydoc_sidebar
permalink: db00795-mesh-d001171-1.html
toc: false 
---


Path ID: `DB00795_MESH_D001171_1`
{% include image.html url="images/db00795-mesh-d001171-1.png" file="db00795-mesh-d001171-1.png" alt="db00795-mesh-d001171-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D012460">MESH:D012460 </a> | Sulfasalazine | Drug |
| <a href="https://identifiers.org/MESH:D019804">MESH:D019804 </a> | Mesalamine | Drug |
| <a href="https://identifiers.org/UniProt:P23219">UniProt:P23219 </a> | Prostaglandin G/H synthase 1 | Protein |
| <a href="https://identifiers.org/UniProt:P35354">UniProt:P35354 </a> | Prostaglandin G/H synthase 2 | Protein |
| <a href="https://identifiers.org/UniProt:P09917">UniProt:P09917 </a> | Polyunsaturated fatty acid 5-lipoxygenase | Protein |
| <a href="https://identifiers.org/UniProt:P37231">UniProt:P37231 </a> | Peroxisome proliferator-activated receptor gamma | Protein |
| <a href="https://identifiers.org/MESH:D011453">MESH:D011453 </a> | Prostaglandins | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D015289">MESH:D015289 </a> | Leukotrienes | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0038061">GO:0038061 </a> | NIK/NF-kappaB signaling | BiologicalProcess |
| <a href="https://identifiers.org/GO:0006954">GO:0006954 </a> | Inflammatory response | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D001171">MESH:D001171 </a> | Juvenile rheumatoid arthritis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Sulfasalazine | HAS METABOLITE | Mesalamine |
| Mesalamine | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 1 |
| Mesalamine | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 2 |
| Mesalamine | DECREASES ACTIVITY OF | Polyunsaturated Fatty Acid 5-Lipoxygenase |
| Mesalamine | INCREASES ACTIVITY OF | Peroxisome Proliferator-Activated Receptor Gamma |
| Prostaglandin G/H Synthase 1 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandin G/H Synthase 2 | INCREASES ABUNDANCE OF | Prostaglandins |
| Polyunsaturated Fatty Acid 5-Lipoxygenase | INCREASES ABUNDANCE OF | Leukotrienes |
| Peroxisome Proliferator-Activated Receptor Gamma | NEGATIVELY REGULATES | Nik/Nf-Kappab Signaling |
| Prostaglandins | POSITIVELY REGULATES | Inflammatory Response |
| Leukotrienes | POSITIVELY REGULATES | Inflammatory Response |
| Nik/Nf-Kappab Signaling | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Juvenile Rheumatoid Arthritis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00795#BE0000248](https://go.drugbank.com/drugs/DB00795#BE0000248)
